Clinical Trial

Prophylactic CD45RA-depleted DLI After Haploidentical Transplantation/RIC

Recruiting Phase 1
View on ClinicalTrials.gov →
Record status
This record was last updated February 13, 2025 (before its estimated June 2, 2026 completion). Its status may not reflect the trial's current state.
Summary
To assess safety of prophylactic escaladed dose of T naïve depleted (CD45RA depleted donor lymphocyte infusion, in patients with malignant hemopathie who received an allogeneic stem cell transplant from an haplo-identical donor, after a reduced intensity conditionning regiment.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2021-10-01.
Status change: Not Yet Recruiting → Recruiting 2025-02-10
Trial Details
NCT Number NCT05066412
Lead Sponsor University Hospital, Geneva
Conditions Hematologic Malignancy, Haplo-identical Stem Cell Transplantation
Enrollment 12 participants
Start Date 2024-11-26
Primary Completion 2026-06-02 (estimated)
Study Completion 2026-12-02 (estimated)
Updated on ClinicalTrials.gov 2025-02-13